Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,163
Recruiting: 2,261
Ph III recruiting: 270
Growth YoY: +12.5%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 701–702 of 702 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03686709	Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment	recruiting	N/A	20	University of TennesseeOTHER	1	Sep 27, 2018	clinicaltrials
NCT01688908	Efficacy of Endoscopy Screening on Esophageal Cancer in China (ESECC)(ESECC)	active not recruiting	N/A	33,948	Peking UniversityOTHER	1	Jan 23, 2018	clinicaltrials